TARRYTOWN, N.Y.--Sept. 25, 2007--Regeneron Pharmaceuticals, Inc.
(Nasdaq: REGN) will webcast its presentation at the UBS Global Life
Sciences Conference on Thursday, September 27, 2007. The presentation
will provide an overview of the Company and its clinical programs and
is scheduled to be broadcast live on Thursday, September 27 at 8:30
a.m. Eastern Time.
The session may be accessed through the Company's
website (www.regeneron.com on the Events Page, under the Investor
Relations heading) at the time of the presentation. An archived
version of the presentation will be available after the live webcast
through October 27, 2007. Additional information about Regeneron and
recent news releases are available on the Regeneron worldwide website
at www.regeneron.com
Regeneron is a biopharmaceutical company that discovers, develops,
and intends to commercialize therapeutic medicines for the treatment
of serious medical conditions. Regeneron has therapeutic candidates
for the potential treatment of cancer, eye diseases, and inflammatory
diseases and has preclinical programs in other diseases and disorders.
The HR industry´s premier online community and resource for Human Resource professionals: HR, human resources, HR community, human resources community, HR best practices, best practices in human resources, online communities for HR, HR articles, HR news, human resources articles, human resources news, HR events, leadership, performance management, staffing and recruitment, benefits, compensation, staffing, recruitment, workforce acquisition, human capital management, HR management, human resources management, HR metrics and measurement, organizational development, executive coaching, HR law, employment law, labor relations, hiring employees, HR outsourcing, human resources outsourcing, training and development
hr.com.
human resources management resources for hr professionals. |
HR menus
|
HR events
|
HR Sitemap